Meet Clarivate at SOT 65th Annual Meeting & ToxExpo 2026
March 23-25, 2026
San Diego Convention Centre
San Diego Convention Centre
Connect with our team at our booth or attend our sessions to discover how Clarivate's data-driven insights accelerate discovery and enhance safety assessments, empowering you to develop smarter, safer drugs faster.
Gain practical, data-driven insights in our poster session into how early safety signals are emerging in the clinic and how they compare with traditional inhibitors and genetic models.
Key takeaways:
This session will feature insights led by Clarivate's industry experts, including perspectives from a valued client, Genmab. It will show through examples how access to OFF-X curated data- integrating diverse data sources, analytics and visualizations- supports the safety assessments for targets of novel bispecific and multispecific antibodies.
Key takeaways:
This session is an Exhibitor-Hosted Session, hosted and presented by Clarivate with industry insights shared by Genmab. Although not an official part of the SOT Annual Meeting scientific program, its presentation is permitted by the Society.
Please note: These sessions are part of the SOT 65th Annual Meeting and ToxExpo 2026, taking place at the San Diego Convention Center in San Diego. You must be registered for the main event to attend these sessions.
Register here for SOT/ToxExpo.
Find out how we empower your toxicology journey, helping you anticipate safety liabilities and mitigate risk at every stage of drug development.
Exclusive first look: See our upcoming AI Safety assistant—designed to streamline preclinical and clinical safety insights for OFF-X decision makers.
Anticipate safety liabilities and mitigate risk in every phase of drug development with OFF-X translational safety intelligence. Access the world's most comprehensive source of preclinical toxicity data.
